These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 32852635)

  • 21. When to Perform Surgical Resection or Radiofrequency Ablation for Early Hepatocellular Carcinoma?: A Nomogram-guided Treatment Strategy.
    Liu PH; Hsu CY; Lee YH; Hsia CY; Huang YH; Su CW; Chiou YY; Lin HC; Huo TI
    Medicine (Baltimore); 2015 Oct; 94(43):e1808. PubMed ID: 26512576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of liver resection and radiofrequency ablation in long-term survival among patients with early-stage hepatocellular carcinoma: a meta-analysis of randomized trials and high-quality propensity score-matched studies.
    Hu L; Lin J; Wang A; Shi X; Qiao Y
    World J Surg Oncol; 2024 Feb; 22(1):56. PubMed ID: 38369480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
    Lee KW; Yi NJ; Suh KS
    Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma.
    Cucchetti A; Piscaglia F; Cescon M; Colecchia A; Ercolani G; Bolondi L; Pinna AD
    J Hepatol; 2013 Aug; 59(2):300-7. PubMed ID: 23603669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic resection combined with radiofrequency ablation versus hepatic resection alone for multifocal hepatocellular carcinomas: A meta-analysis.
    Xu LL; Zhang M; Yi PS; Zheng XB; Feng L; Lan C; Tang JW; Ren SS; Xu MQ
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):974-980. PubMed ID: 29270762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LI-RADS category is associated with treatment outcomes of small single HCC: surgical resection vs. radiofrequency ablation.
    Min JH; Lee MW; Rhim H; Han S; Song KD; Kang TW; Jeong WK; Cha DI; Kim JM; Choi GS; Kim K
    Eur Radiol; 2024 Jan; 34(1):525-537. PubMed ID: 37526668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of FDG-PET and UCSF Criteria for Predicting HCC Recurrence After Living Donor Liver Transplantation.
    Hsu CC; Chen CL; Wang CC; Lin CC; Yong CC; Wang SH; Liu YW; Lin TL; Lee WF; Lin YH; Chan YC; Wu YJ; Eng HL; Cheng YF
    Transplantation; 2016 Sep; 100(9):1925-32. PubMed ID: 27306534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeat hepatic resection combined with intraoperative radiofrequency ablation versus repeat hepatic resection alone for recurrent and multiple hepatocellular carcinoma patients meeting the Barcelona Clinic Liver Cancer stage A: A propensity score-matched analysis.
    Huang Y; Xu L; Huang M; Jiang L; Xu M
    Cancer Med; 2023 Apr; 12(8):9213-9227. PubMed ID: 36722129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of neoadjuvant conventional transarterial chemoembolization with radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma after initial hepatectomy with microvascular invasion.
    Peng Z; Wu X; Li J; Pang H; Zhang Y; Lin M; Wang Z; Xiao H; Li B; Chen M; Feng S; Kuang M; Chen S
    Int J Hyperthermia; 2022; 39(1):688-696. PubMed ID: 35469522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Childs A cirrhotics-a retrospective study of 1,061 cases.
    Huang J; Hernandez-Alejandro R; Croome KP; Yan L; Wu H; Chen Z; Prasoon P; Zeng Y
    J Gastrointest Surg; 2011 Feb; 15(2):311-20. PubMed ID: 21052859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation.
    Bhangui P; Vibert E; Majno P; Salloum C; Andreani P; Zocrato J; Ichai P; Saliba F; Adam R; Castaing D; Azoulay D
    Hepatology; 2011 May; 53(5):1570-9. PubMed ID: 21520172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic resection for transplantable hepatocellular carcinoma for patients within Milan and UCSF criteria.
    Chua TC; Saxena A; Chu F; Morris DL
    Am J Clin Oncol; 2012 Apr; 35(2):141-5. PubMed ID: 21336092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incorporating Tumor Biology to Predict Hepatocellular Carcinoma Recurrence in Patients Undergoing Living Donor Liver Transplantation Using Expanded Selection Criteria.
    Bhangui P; Saigal S; Gautam D; Piplani T; Choudhary N; Chaudhary R; Yadav S; Thiagarajan S; Rastogi A; Saraf N; Nundy S; Soin AS
    Liver Transpl; 2021 Feb; 27(2):209-221. PubMed ID: 33253492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined resection and radiofrequency ablation versus transarterial embolization for intermediate-stage hepatocellular carcinoma: A propensity score matching study.
    Espinosa W; Liu YW; Wang CC; Lin CC; Wang JH; Lu SN; Hung CH
    J Formos Med Assoc; 2018 Mar; 117(3):197-203. PubMed ID: 28411877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small masses (≤3 cm) diagnosed as hepatocellular carcinoma on pre-treatment imaging: comparison of therapeutic outcomes between hepatic resection and radiofrequency ablation.
    Cha DI; Song KD; Kang TW; Lee MW; Rhim H
    Br J Radiol; 2020 Jan; 93(1105):20190719. PubMed ID: 31670571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined percutaneous radiofrequency ablation and ethanol injection versus hepatic resection for 2.1-5.0 cm solitary hepatocellular carcinoma: a retrospective comparative multicentre study.
    Chen S; Peng Z; Lin M; Chen Z; Hu W; Xie X; Liu L; Qian G; Peng B; Li B; Kuang M
    Eur Radiol; 2018 Sep; 28(9):3651-3660. PubMed ID: 29600474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiofrequency ablation versus surgical resection for the treatment of solitary hepatocellular carcinoma 2 cm or smaller: A cohort study in Taiwan.
    Wu CC; Tseng CW; Tseng KC; Chen YC; Wu TW; Chang SY; Chang YJ; Chao YC; Hsu CS
    J Formos Med Assoc; 2021 May; 120(5):1249-1258. PubMed ID: 33288401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ≤ 2 cm with compensated liver cirrhosis.
    Lin CH; Ho CM; Wu CH; Liang PC; Wu YM; Hu RH; Lee PH; Ho MC
    Surg Endosc; 2020 Dec; 34(12):5566-5573. PubMed ID: 31993821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Appropriate treatment modality for solitary small hepatocellular carcinoma: Radiofrequency ablation vs. resection vs. transplantation?
    Ahn KS; Kang KJ
    Clin Mol Hepatol; 2019 Dec; 25(4):354-359. PubMed ID: 31006225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.